A detailed history of Neuberger Berman Group LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 116,337 shares of CORT stock, worth $5.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116,337
Holding current value
$5.92 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $3.43 Million - $5.38 Million
116,337 New
116,337 $5.38 Million
Q4 2017

Feb 14, 2018

SELL
$15.77 - $20.72 $629,081 - $826,541
-39,891 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$12.3 - $19.3 $490,659 - $769,896
39,891
39,891 $770,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.45B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.